Evaluation of patients affected by inherited metabolic disorders (IMDs) in adult centres: a snapshot from the first multi-centre Italian survey from the Italian society for the study of hereditary metabolic diseases and newborn screening (SIMMESN) ad

Abstract Background The increasing survival of patients with inherited metabolic disorders (IMDs) has led to a growing adult population requiring specialized care. Adult Metabolic Medicine (AMM) is therefore an expanding field, yet its organization in Italy has not been systematically evaluated. This study aimed to assess the structure, resources, and unmet needs of Italian Centres managing adult IMD patients. A 50-item survey was developed by the Adult Metabolic Working Group and distributed to all Italian Adult Centres affiliated with SIMMESN (Italian Society of Metabolic Disease and NBS) or MetabERN (European Reference Network for Metabolic Disorders). The questionnaire collected data on centre characteristics, staffing, facilities, patient population, and transition from paediatric to adult care. The survey was active from April 2022 to April 2023. Data were analysed using descriptive statistics. Results Twenty Centres responded, reporting 2,175 adult IMD patients. Centres were heterogeneously distributed across Italy, with limited representation in southern regions. Most were university hospitals (65%), and only 20% were exclusively dedicated to IMDs. Although 95% conducted research and all were eligible for clinical trials, only 55% had an in-house metabolic laboratory, and 65% provided dedicated inpatient beds. Staffing was limited (mean two physicians per Centre), with inconsistent availability of dedicated nurses, dieticians, and psychologists. The most prevalent conditions were lysosomal storage disorders (38.5%), mitochondrial disorders (18.6%), and amino acid disorders (16%). Only 30% of Centres had a formalized transition program. Based on expected annual transitions, the adult IMD population is projected to increase by 13.45% annually, doubling in approximately 7.4 years. Conclusions Adult IMD services in Italy are rapidly expanding but remain heterogeneous and under-resourced. National standards, structured transition pathways, and dedicated AMM training programs are urgently needed to ensure sustainable and equitable care.

Authors

Institutions

Publication Details

Journal
Orphanet Journal of Rare Diseases
Published
2026-11-12
DOI
https://doi.org/10.1186/s13023-026-04693-9
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of patients affected by inherited metabolic disorders (IMDs) in adult centres: a snapshot from the first multi-centre Italian survey from the Italian society for the study of hereditary metabolic diseases and newborn screening (SIMMESN) ad

Davide Noto, Maria Letizia Urban, Annalia Cianflone, Francesca Carubbi et al.
Orphanet Journal of Rare Diseases
Metabolism and Genetic Disorders
article

Evaluation of patients affected by inherited metabolic disorders (IMDs) in adult centres: a snapshot from the first multi-centre Italian survey from the Italian society for the study of hereditary metabolic diseases and newborn screening (SIMMESN) ad

Davide Noto, Maria Letizia Urban, Annalia Cianflone, Francesca Carubbi, Massimiliano Filosto, Claudia Sgattoni, Annalisa Sechi, Nicola Vitturi, Paola Mandich, Alessandro P. Burlina, Elena Verrecchia, Olimpia Musumeci, Antonio Barbato, Giuliana Da Prato, Lucia Brodosi, Andrea Silvio Benso, Giacomo Marchi, Irene Motta, Mariarosa Anna Beatrice Marina Melone, Michelangelo Mancuso
article en

Abstract

Abstract Background The increasing survival of patients with inherited metabolic disorders (IMDs) has led to a growing adult population requiring specialized care. Adult Metabolic Medicine (AMM) is therefore an expanding field, yet its organization in Italy has not been systematically evaluated. This study aimed to assess the structure, resources, and unmet needs of Italian Centres managing adult IMD patients. A 50-item survey was developed by the Adult Metabolic Working Group and distributed to all Italian Adult Centres affiliated with SIMMESN (Italian Society of Metabolic Disease and NBS) or MetabERN (European Reference Network for Metabolic Disorders). The questionnaire collected data on centre characteristics, staffing, facilities, patient population, and transition from paediatric to adult care. The survey was active from April 2022 to April 2023. Data were analysed using descriptive statistics. Results Twenty Centres responded, reporting 2,175 adult IMD patients. Centres were heterogeneously distributed across Italy, with limited representation in southern regions. Most were university hospitals (65%), and only 20% were exclusively dedicated to IMDs. Although 95% conducted research and all were eligible for clinical trials, only 55% had an in-house metabolic laboratory, and 65% provided dedicated inpatient beds. Staffing was limited (mean two physicians per Centre), with inconsistent availability of dedicated nurses, dieticians, and psychologists. The most prevalent conditions were lysosomal storage disorders (38.5%), mitochondrial disorders (18.6%), and amino acid disorders (16%). Only 30% of Centres had a formalized transition program. Based on expected annual transitions, the adult IMD population is projected to increase by 13.45% annually, doubling in approximately 7.4 years. Conclusions Adult IMD services in Italy are rapidly expanding but remain heterogeneous and under-resourced. National standards, structured transition pathways, and dedicated AMM training programs are urgently needed to ensure sustainable and equitable care.

Orphanet Journal of Rare Diseases
Università Cattolica del Sacro Cuore (IT), University of Pisa (IT), University of Messina (IT), University of Verona (IT), University of Modena and Reggio Emilia (IT), University of Udine (IT), University of Padua (IT), University of Trieste (IT), University of Milan (IT), University of Campania "Luigi Vanvitelli" (IT), Agostino Gemelli University Polyclinic (IT), Azienda Ospedaliera Universitaria Integrata Verona (IT), Ospedale di Cattinara (IT), IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT), Azienda Ospedaliero Universitaria Ospedali Riuniti (IT), Azienda Ospedaliera San Gerardo (IT), Federico II University Hospital (IT), Ospedale San Bassiano (IT), Ospedale Policlinico San Martino (IT), Azienda Ospedale - Università Padova (IT), University of Turin (IT), University of Naples Federico II (IT), University of Brescia (IT), University of Genoa (IT), University of Palermo (IT), University of Bologna (IT)
Good health and well-being
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon